ANG Lifesciences India Limited (BOM:540694)
19.31
-0.32 (-1.63%)
At close: Mar 27, 2026
ANG Lifesciences India Market Cap
ANG Lifesciences India has a market cap or net worth of 252.16 million as of March 27, 2026. Its market cap has decreased by -49.17% in one year.
Market Cap
252.16M
Enterprise Value
1.12B
Revenue
862.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.31
Market Cap Chart
Since September 8, 2017, ANG Lifesciences India's market cap has decreased from 497.60M to 252.16M, a decrease of -49.33%. That is a compound annual growth rate of -7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 252.16M | -34.65% |
| Dec 31, 2025 | 385.87M | -33.77% |
| Dec 31, 2024 | 582.66M | -35.72% |
| Dec 29, 2023 | 906.38M | -42.23% |
| Dec 30, 2022 | 1.57B | -67.78% |
| Dec 31, 2021 | 4.87B | 1,136.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panjon | 394.78M |
| Murae Organisor | 353.20M |
| Sandu Pharmaceuticals | 328.47M |
| Welcure Drugs and Pharmaceuticals | 321.34M |
| JFL Life Sciences | 292.01M |
| Gujarat Terce Laboratories | 263.97M |
| Rekvina Laboratories | 210.08M |
| Deccan Health Care | 193.49M |